Loratadine
Loratadine, sold under the brand name Claritin among others, is a medication used to treat allergies. This includes allergic rhinitis (hay fever) and hives. It is also available in drug combinations such as loratadine/pseudoephedrine, in which it is combined with pseudoephedrine, a nasal decongestant. It is taken orally.
Clinical data | |
---|---|
Trade names | Claritin, Claratyne, Clarityn, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a697038 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth |
Drug class | Second-generation antihistamine |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | almost 100% |
Protein binding | 97–99% |
Metabolism | Liver (CYP2D6- and 3A4-mediated) |
Elimination half-life | 8 hours, active metabolite desloratadine 27 hours |
Excretion | 40% as conjugated metabolites into urine Similar amount into the feces |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.120.122 |
Chemical and physical data | |
Formula | C22H23ClN2O2 |
Molar mass | 382.89 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Common side effects include sleepiness, dry mouth, and headache. Serious side effects are rare and include allergic reactions, seizures, and liver problems. Use during pregnancy appears to be safe but has not been well studied. It is not recommended in children less than two years old. It is in the second-generation antihistamine family of medication.
Loratadine was patented in 1980 and came to market in 1988. It is on the World Health Organization's List of Essential Medicines. Loratadine is available as a generic medication. In the United States, it is available over the counter. In 2021, it was the 67th most commonly prescribed medication in the United States, with more than 9 million prescriptions.